This data article features supplementary figures and tables related to the article "Differential Multivariable risk prediction of appropriate shock vs. competing mortality -a prospective cohort study to estimate benefits from implantable cardioverter defibrillator therapy" (Bergau et al., 2018) [1]. The figures show the clinical study CONSORT graph (data that show the number of patients not-analyzable as well as a distribution of patients by outcomes) and the correlation scatter plot for risk scores of appropriate shock vs. mortality (data that show the calculated score values of the two scores plotted against each other).
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Value of the data
The CONSORT graph data of the prospective clinical study is shown, giving insight into the distribution of patient subjects in the study.
The correlation scatter plot data for calculated risk score values of appropriate shock vs. calculated risk score value for mortality is shown, original pairs of score values can be discerned in the graphics and are shared as a file.
The univariate Cox regression data for prediction of mortality and appropriate shock (unadjusted and adjusted for base model) are shown, giving insights into the basic statistical data before multivariate analyses.
Data
The data article features supplementary figures and tables related to [1] . See the abstract above for further details describing the data.
Experimental design, materials and methods
A prospective international clinical study was initiated as part of the European Union Seventh
Framework funded large-scale cooperative project EUTrigTreat. The rationale, objectives and design of the study including statistical plan and sample size calculations have been published previously. In brief, the study enrolled a contemporary implantable cardioverter defibrillator cohort to test multiple carefully selected risk markers of clinical relevance for prediction of mortality and arrhythmias. The large majority of patients underwent non-invasive programmed ventricular stimulation via their implanted ICDs. Inducibility of sustained ventricular arrhythmia was defined as induction of a single monomorphic ventricular tachycardia lasting for 30 seconds or two polymorphic ventricular tachycardia/ventricular fibrillation episodes requiring cardioversion. A 24-h Holter monitoring was performed using standard devices. The primary endpoint was all-cause mortality. First appropriate implantable cardioverter defibrillator shock was selected as a key secondary endpoint. Cox regression analysis was implemented as described. Risk models for shock and mortality were developed using forward selection among a set of known potential risk factors ( Figs. 1 and 2 and Tables 1-3 shows that the correlation is at best moderate despite mathematical significance. Thus, all-cause mortality risk does not coincide well with appropriate shock risk. Individually, a low risk of appropriate shock does occur with a high competing risk of death limiting the effectiveness of implantable cardioverter defibrillator therapy in a given patient (lower right quadrant). Vice versa, individual patients can be identified with fairly high risks of appropriate shock and concomitant moderate risks of death (upper left quadrant). These individuals are expected to have a higher life-prolonging effect of their implantable cardioverter defibrillator therapy, i.e. higher implantable cardioverter defibrillator benefit. The original score values are attached in a table (csv file). (Open field ¼ no adjusted value available, AF ¼ atrial fibrillation, CI ¼ confidence interval, COPD ¼ chronic obstructive pulmonary disease, eGFR ¼ estimated glomerular filtration rate, DC ¼ deceleration capacity, HR ¼ hazard ratio, HRT ¼ heart rate turbulence, hs-CRP ¼ high-sensitivity C-reactive protein, ICD ¼ implantable cardioverter defibrillator, EP ¼ electrophysiological, LVEF ¼ left ventricular ejection fraction, MTWA ¼ microvolt T-wave alternans, PVC ¼ premature ventricular contraction, nsVT ¼ non-sustained ventricular tachycardia, NT-pro-BNP ¼ n-terminal-pro-brain natriuretic peptide, NYHA ¼ New York Heart Association functional class, SDNN ¼ standard deviation of RR intervals, RMSSD ¼ mean square root of mean of squared differences between normal-to-normal RR intervals, TO ¼ turbulence onset, TS ¼ turbulence slope). 
